Navigation Links
Vantage Health South African Subsidiary Negotiates Supply Agreement With Major South African Retail Group
Date:8/2/2011

CAPE TOWN, South Africa, Aug. 02, 2011 /PRNewswire/ -- Vantage Health (OTC:BB – ticker symbol VNTH), ("Vantage"), announced today that its 51% owned South African subsidiary, Moxisign (PTY) Ltd., ("Moxisign"), is finalizing a pricing structure for a Supply Agreement with the generic pharmaceutical division of a major Johannesburg Stock Exchange listed retail group. The umbrella Supply Agreement, ("contract") with the various appendices detailing each pharmaceutical product to be supplied is expected to be fully executed before the end of September, 2011. Because of the time required to have each of Moxisign's drug dossiers registered with South Africa's Medicine Control Council ("MCC") before supply can begin, the contract is expected to run from January 2013 for a renewable five year term, and will cover various generic pharmaceutical products. As such, and subject to the final Supply Agreement being executed by all relevant parties, revenues from this contract will only be generated once MCC approves each drug dossier. The contract provides for additional generic drugs to be added by Moxisign for the duration of the contract term.

Dr. Lisa Ramakrishnan, President and CEO of Vantage Health, noted: "It has always been our intention to have our Moxisign subsidiary focused on the South African private sector as an adjunct to its public sector efforts. In terms of volume potential, we had, as one of our main priorities, the goal of partnering with an established and significant South African retail entity."

About Vantage Health

Vantage Health is an African based health care products and medical consumables supply company focused on building its core supply business through government and local partnerships, and alleviating the burden of HIV/AIDS and disease on the African continent. The company currently has two subsidiaries, Moxisign (PTY) Ltd., a South African entity 49% owned by Kopano Ke Matla Investment Company, the investment
'/>"/>

SOURCE Vantage Health
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
2. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
3. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
4. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
5. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
6. St. Jude Finds Young Age May Give Survival Advantage to Children With Certain Brain Tumors
7. Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs
8. Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
9. Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
10. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
11. Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... 2013 Today Moscamed made the first ... a new programme to control the dengue mosquito Aedes ... of Bahia. In previous trials Moscamed have demonstrated ... reduce the number of dengue mosquitoes in a town. In ... mosquitoes were reduced by 96% within 6 months and it ...
(Date:6/19/2013)... CHICAGO , June 19, 2013 Dr. ... been named one of four recipients of the 2013 ... achievement in applied medical informatics. "On ... for his recognition in leadership, innovation and continuous efforts ... Paul M. Black , President and Chief Executive Officer ...
(Date:6/19/2013)... Amgen is pleased to announce the nine science ... Canada and Puerto Rico ... for Science Teaching Excellence (AASTE). Now in its 21st year, ... grade level who have an outstanding ability to inspire students ... long-standing commitment to science education, Amgen established the teacher awards ...
Breaking Medicine Technology:Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 2Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 2Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 5Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 2Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 3
... The deadly E. coli O104 ... has been sequenced using 454,Life Sciences, benchtop GS Junior ... analysis to date" of this,particularly virulent strain. [ ... at the UK,s Health,Protection Agency and the data has ...
... NEW YORK, June 15, 2011 ... research report is available in its ... in Medical Devices - Number of ... Devices Companies has Increased in the ...
Cached Medicine Technology:Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date 2Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date 3Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years 2Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years 3Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years 4Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years 5Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years 6Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years 7Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years 8Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years 9Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years 10Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years 11
(Date:6/20/2013)... June 20, 2013 Anant Goel, CEO at ... is to empower children and adults with skills of the ... skills that form the foundation for success in the new ... but having access to technology does not automatically make us ... needed for work, businesses, and life." , ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 The ISA ... agricultural and trade communities, announced their 6th annual international ... in Potsdam, Germany. , Bruce McMullin , ... the man greatly responsible for introducing the benefits of ... attending this year’s conference. Sibu grows and harvests sea ...
(Date:6/20/2013)... York (PRWEB) June 20, 2013 As ... and misfolding, Navneet Tyagi has remained closely ... Throughout the myriad of scientific research that Tyagi has ... of identifying early onset of these severe and mysterious ... diagnosis, more medical researchers will be able to understand ...
(Date:6/20/2013)... Rampant staph infections continue to cost lives ... is being successfully deployed by China's military: industrial hemp. ... touching items that are contaminated such as towels, sheets, ... San Francisco Chronicle , “It is estimated that ... stays, and at least 90,000 of them die. ...
(Date:6/20/2013)... During a June 13 panel discussion ... Maryland Health Benefit Exchange confirmed the existence of the ... the industry consider,” writes panel moderator Steve Davis in ... as unicorns and leprechauns.” , “We are the only ... Services Hub live,” Rebecca Pearce told attendees at Gorman ...
Breaking Medicine News(10 mins):Health News:RKNet Studio Launched Online Website for Fun Games, Brain Training and Cognitive Skills Development 2Health News:RKNet Studio Launched Online Website for Fun Games, Brain Training and Cognitive Skills Development 3Health News:Sibu, LLC CEO, Bruce McMullin to be Amongst Distinguished Attendees at ISA Conference 2Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 2Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 3Health News:Lab Testing Reveals EnviroTextile's Hemp Fabric Stops the Spread of Staph Bacteria 2Health News:Lab Testing Reveals EnviroTextile's Hemp Fabric Stops the Spread of Staph Bacteria 3Health News:Federal Data Services Hub Does Exist, AISHealth.com Blog Post Reports 2
... Skp2 gene and its relation to cellular senescence may lead ... development in common types of cancer, researchers from The University ... Cancer Center report in the journal Nature . ... proliferation, cell growth and the formation of tumors, and it ...
... don,t mean lowered interest for most women , WEDNESDAY, ... sex as their pregnancy progresses, they don,t enjoy the ... studied men,s sexual health for many years, and we ... problems in the past, and there,s a gender information ...
... , WASHINGTON , March 17 The National Association of Professional Insurance Agents (PIA) has named Louisiana Congressman Charlie Melancon its 2010 ... ... ... ...
... ROCKVILLE, Md. , March 15 Heart patients who took ... blood clots – were only half as likely to be hospitalized for upper ... study supported by HHS, Agency for Healthcare Research and Quality and the National ... ...
... mothers. Instead, they feel ashamed and inadequate, and fearful that ... ordinary Norwegian home, where Mum is having dinner with her ... the woman is fighting a fierce battle with herself, thinking: ... to the bathroom and throw up." This is just ...
... , ... A practice offering vein treatment and cosmetic plastic surgery ... the latest breakthrough laser technology in the treatment of skin affected by ... with the Vein & Cosmetic Center of Tampa Bay utilizes CO2 Fractional ...
Cached Medicine News:Health News:Disabling Skp2 gene helps shut down cancer growth 2Health News:Sexual Desire, Satisfaction Don't Diminish During Pregnancy 2Health News:Sexual Desire, Satisfaction Don't Diminish During Pregnancy 3Health News:Professional Insurance Agents Name Rep. Charlie Melancon 2010 Legislator of the Year 2Health News:Professional Insurance Agents Name Rep. Charlie Melancon 2010 Legislator of the Year 3Health News:Professional Insurance Agents Name Rep. Charlie Melancon 2010 Legislator of the Year 4Health News:Patients Who Take a Proton-Pump Inhibitor With Medicine to Prevent Blood Clots Are Less Likely to Be Hospitalized for Bleeding Ulcers 2Health News:Patients Who Take a Proton-Pump Inhibitor With Medicine to Prevent Blood Clots Are Less Likely to Be Hospitalized for Bleeding Ulcers 3Health News:When mom has an eating problem 2Health News:When mom has an eating problem 3Health News:Tampa Bay Vein Treatment and Cosmetic Dermatology Practice Using New Laser Technology Some Say is the Latest Breakthrough 2Health News:Tampa Bay Vein Treatment and Cosmetic Dermatology Practice Using New Laser Technology Some Say is the Latest Breakthrough 3Health News:Tampa Bay Vein Treatment and Cosmetic Dermatology Practice Using New Laser Technology Some Say is the Latest Breakthrough 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: